整合基于人工智能的集群,分子动力学和结合能分析,以阐明细胞外信号调节激酶1和2复合体中的构造动力学和结合选择性
1Department of Computer Information Systems, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Bioinformatics and biology insights
|March 6, 2026
概括
开发针对细胞外信号调节激酶1和2 (ERK1/2) 的选择性小分子抑制剂具有挑战性. 这项研究使用分子动力学 (MD) 和人工智能 (AI) 来揭示抑制剂如何影响ERK1/2的灵活性和结合,确定38Z是最好的结合剂,Z48是稳定剂.
科学领域:
- 生物化学和分子生物学
- 计算化学的计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 细胞外信号调节激酶1和2 (ERK1/2) 在细胞信号通路中至关重要.
- 开发ERK1/2的选择性小分子抑制剂受到其结构相似性和灵活性的阻碍.
- 了解ERK1/2的结构动态是设计有效抑制剂的关键.
研究的目的:
- 研究ERK1/2-抑制剂复合物的构造动态和结合选择性.
- 将分子动力学 (MD) 模拟与人工智能 (AI) 结合起来,以进行增强的分析.
- 为了确定与ERK1/2异型的抑制剂相互作用的关键特征.
主要方法:
- 经典分子动力学 (MD) 模拟ERK1/2与抑制剂33A,38Z和Z48.8结合.
- 基于AI的无监督学习:主要组件分析 (PCA),t分布式随机邻居嵌入 (t-SNE) 和K-means集群.
- 免费能源景观绘制,状态过渡分析,以及MM/GBSA具有约束力的免费能源计算.
主要成果:
- ERK2复合体显示出比ERK1复合体更大的结构稳定性.
- 人工智能揭示了不同的形状盆地,表明ERK灵活性的联体特异调节.
- 抑制剂38Z表现出最强的结合亲和力,由范德瓦尔斯相互作用驱动,而Z48增强了形状稳定.
结论:
- 结合的MD-AI框架为ERK1/2的形状可塑性和抑制剂选择性提供了原子学的洞察力.
- 抑制剂38Z是能量最有利的粘合剂,而Z48是最有效的形状稳定剂.
- 这些发现可以指导下一代选择性激酶抑制剂的合理设计,用于ERK1/2.2.
相关概念视频
Assembly of Signaling Complexes
6.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.8K
Cooperative Allosteric Transitions
9.2K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.2K
Cooperative Allosteric Transitions
2.8K
2.8K
The Equilibrium Binding Constant and Binding Strength
15.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.4K
MAPK Signaling Cascades
8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Ligand Binding and Linkage
5.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.8K


